Free Case Evaluations for Zantac Users Diagnosed with Cancer
Did you or a loved one take the antacid drug Zantac regularly for at least 60 days only to later die or be diagnosed with cancer? If so, please contact a Zantac cancer lawsuit attorney today for a FREE consultation and evaluation, as you may be entitled to monetary compensation for your pain and suffering/other damages such as costs associated with funeral expenses.
What Is Zantac?
Zantac, otherwise known as ranitidine hydrochloride (hcl), is a prescribed or over-the-counter drug millions of heartburn and acid reflux sufferers have taken to help relieve and treat gastrointestinal issues. The drug has also been used to treat and prevent ulcers in the stomach, throat, and intestines. Zantac was widely available in daily dosage amounts of 75, 150, or 300 mg.
FDA Safety Notice and 2020 Recall
On September 13, 2019 the U.S. Food and Drug Administration (FDA) released a statement to the public pertaining to a safety issue regarding NDMA:
FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
Furthermore, the (FDA) found that Zantac 150 mg tablets contain a nitrosamine impurity that is classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC) and EPA. The carcinogenic chemical found is known as N-nitrosodimethylamine (NDMA) and is said to be at levels well over the FDA’s current acceptable daily intake limit of 96 ng per day.
However, despite these test findings, the FDA did not recall notice for Zantac at the time. In fact, the agency didn’t even recommend people to stop taking the heartburn drug, although it did admonish that alternative medications are available.
Conversely, major stores across the United States have removed Zantac from their shelves. Retailers that no longer sell the medication include:
- Rite Aid
On April 1, 2020 the FDA requested that manufacturers withdraw Zantac and all other ranitidine drugs from the market immediately. The agency has acknowledged that Zantac contains the NDMA impurity and that it could become even more deadly depending on how it is stored. The FDA’s latest statement included the following:
The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S.
What Is NDMA?
N-nitrosodimethylamine (NDMA) is a known environmental contaminant that is found in water, meats, dairy products, vegetables, and other food items. It is also a chemical bi-product that results when a Zantac tablet is broken down and transformed by digestive enzymes found in human livers.
Makers of Zantac allegedly failed to take proper safety measures to test for health risks prior to releasing the drug to consumers. They also allegedly knew about the design defect and released the antacid anyway.
You or your loved one should not have been put at risk of developing cancer because of negligence. At Mike Brandner Injury Attorneys, we value your health over profit. Claim your free Zantac cancer lawsuit evaluation now to learn more about your legal options. You may be entitled to compensation to cover lost wages, medical bills, pain and suffering, or costs associated with a wrongful death.
2019 Zantac Cancer Lawsuit
Mark Allan Blake was diagnosed with bladder cancer after having taken Zantac for an extended amount of time. On October 21, 2019, he filed one of the first Zantac cancer lawsuits. His case, Blake v. Boehringer Ingelheim Pharmaceuticals, Inc. et al (case 1:19-cv-02991-MEH), was filed in the state of Colorado.
Pfizer Inc., Sanofi US Services Inc., and other drug companies are named as defendants in the lawsuit for failure to warn him of the cancer risk associated with taking the antacid drug Zantac. Further, Blake states that their failure to warn resulted in him developing bladder cancer.
Get a Free Zantac Cancer Lawsuit Case Evaluation
You may be entitled to compensation through a Zantac cancer lawsuit if you regularly took Zantac for at least 60 days and were then later diagnosed with:
- Bladder cancer
- Stomach cancer
- Liver cancer
At Mike Brandner Injury Attorneys, our legal team is prepared to go up against large pharmaceutical companies and drug manufacturers. We know that no amount of money can make up for the loss of a loved one, or the pain and suffering experienced after a cancer diagnosis. However, it can provide a small amount of comfort by covering medical expenses, lost wages, and loss of consortium. Please contact us today to get your free Zantac cancer lawsuit cancer evaluation.
You can connect with us 24/7 through our convenient online LiveChat feature or by sharing more details about your health history through a web contact form. You can also give us a call at (504) 345-1111 day or night, or stop by our office Monday – Friday, from 8:00 a.m. to 5:00 p.m.